Business● Low1h ago · Nov 6, 2026, 10:35 AM
MannKind anticipates $1B in revenue from United Therapeutics deal from 2027-2030 as it targets Q4 profitability
GlobeAlert Desk · curated from Seeking Alpha Tech · global
MannKind anticipates achieving $1 billion in revenue from a deal with United Therapeutics between 2027 and 2030. The company is also targeting profitability in the fourth quarter, signaling potential growth and financial stability.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business18m agoTony Elumelu: "We must industrialize Africa, no one else will do it"Jeune AfriqueBusiness19m agoDelek US beats top-line and bottom-line estimates; raises FY26 outlookSeeking Alpha TechBusiness20m agoEssent Group GAAP EPS of $1.82 misses by $0.05, revenue of $374.18M beats by $9.89MSeeking Alpha TechBusiness21m agoBrookdale Senior Living GAAP EPS of -$0.06 misses by $0.03, revenue of $707.1M misses by $9.9MSeeking Alpha Tech